Vertex Pharmaceuticals | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 370.64B 56.62B 2025-03
Alnylam Pharmaceuticals USD 35.13B 4.7B 2025-03
Amgen USD 139.96B 33.39B 2024-12
Arrowhead Research USD 2.34B 69M 2024-12
BioMarin Pharmaceutical USD 12.54B 855M 2024-12
Bristol-Myers Squibb USD 124.1B 9.39B 2025-03
Gilead Sciences USD 139.68B 24.59B 2025-03
Incyte USD 11.72B 1.59B 2025-03
Insmed USD 12.38B 676M 2024-12
Ionis Pharmaceuticals USD 4.8B 722M 2025-03
J&J USD 399.65B 51.46B 2025-03
Merck USD 225.87B 25.78B 2025-03
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 143.72B 6.63B 2025-03
PTC Therapeutics USD 3.51B 653M 2024-12
Sanofi EUR 125.84B 7.44B 2025-03
Sarepta Therapeutics USD 11.78B 128M 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
United Therapeutics USD 13.89B 1.86B 2025-03
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Vertex Pharmaceuticals Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.